%0 Clinical Study
%T Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors.
%A Freedman RA
%A Revette AC
%A Gagnon H
%A Perilla-Glen A
%A Kokoski M
%A Hussein SO
%A Leone E
%A Hixon N
%A Lovato R
%A Loeser W
%A Lin NU
%A Minami CA
%A Canin B
%A LeStage B
%A Faggen M
%A Poorvu PD
%A McKenna J
%A Ruddy KJ
%A Keating NL
%A Schonberg MA
%A Freedman RA
%A Revette AC
%A Gagnon H
%A Perilla-Glen A
%A Kokoski M
%A Hussein SO
%A Leone E
%A Hixon N
%A Lovato R
%A Loeser W
%A Lin NU
%A Minami CA
%A Canin B
%A LeStage B
%A Faggen M
%A Poorvu PD
%A McKenna J
%A Ruddy KJ
%A Keating NL
%A Schonberg MA
%J Breast Cancer Res Treat
%V 195
%N 2
%D Sep 2022
%M 35908120
%F 4.624
%R 10.1007/s10549-022-06676-3
%X <B>OBJECTIVE: </B>To support shared decision-making, patient-facing resources are needed to complement recently published guidelines on approaches for surveillance mammography in breast cancer survivors aged ≥ 75 or with < 10-year life expectancy. We created a patient guide to facilitate discussions about surveillance mammography in older breast cancer survivors.<BR><B>METHODS: </B>The "Are Mammograms Still Right for Me?" guide estimates future ipsilateral and contralateral breast (in-breast) cancer risks, general health, and the potential benefits/harms of mammography, with prompts for discussion. We conducted in-clinic acceptability testing of the guide by survivors and their clinicians at a National Cancer Institute-designated comprehensive cancer center, including two community practices. Patients and clinicians received the guide ahead of a clinic visit and surveyed patients (pre-/post-visit) and clinicians (post-visit). Acceptability was defined as ≥ 75% of patients and clinicians reporting that the guide (a) should be recommended to others, (b) is clear, (c) is helpful, and (d) contains a suitable amount of information. We also elicited feedback on usability and mammography intentions.<BR><B>RESULTS: </B>We enrolled 45 patients and their 21 clinicians. Among those responding in post-visit surveys, 33/37 (89%) patients and 15/16 (94%) clinicians would recommend the guide to others; 33/37 (89%) patients and 15/16 (94%) clinicians felt everything/most things were clear. All other pre-specified acceptability criteria were met. Most patients reported strong intentions for mammography (100% pre-visit, 98% post-visit).<BR><B>CONCLUSIONS: </B>Oncology clinicians and older breast cancer survivors found a guide to inform mammography decision-making acceptable and clear. A multisite clinical trial is needed to assess the guide's impact mammography utilization.<BR><B>BACKGROUND: </B>ClinicalTrials.gov-NCT03865654, posted March 7, 2019.